Oarsman Outlook: April 2020

Pandemic 2020: One Month In The COVID-19 pandemic, an archetypal “black swan” event, has upended the global economy and financial markets (not to mention our daily lives). As the implications of the crisis came into focus in late February, swaths of the financial...

Oarsman Outlook: January 2020

The final three months of 2019 featured robust results from nearly all investment categories.  The advance was paced by 8% to 10% gains by both large- and small-company U.S. stocks.  Overseas, developed and frontier markets rose a bit less, though the emerging-market...

The Oarsman Outlook: October 2019

Summer saw modest advances by major investment categories, adding to already substantial year-to-date gains.  Large-company U.S. stocks gained around 2%, though small-caps declined by a similar amount.  Many overseas markets posted modestly positive results in local...

The Oarsman Outlook: July 2019

Nearly all financial investments provided solidly positive results during the April-June period, adding to a strong and broad-based early-year advance.  Both large-company U.S. stocks and developed-market overseas equities advanced around 4% on the quarter;...

The Oarsman Outlook: April 2019

What a difference three months make!  On the heels of last-year’s horrific final act, the opening quarter of 2019 featured heroic rebounds in the prices of nearly all investment categories.  Major U.S. stock indices jumped 12% to 14%, with growth-oriented and...

Oarsman Outlook: January 2019

Investors will not remember the final three months of 2018 fondly.  In the worst quarterly performance since the Global Financial Crisis, most investment categories suffered substantial losses.  Large-company U.S. stocks fell nearly 15%; small-company stocks plunged...